Abstract: The fourth-party logistics service platform aims to integrate logistics services from various providers to offer a one-stop logistics solution to customers. However, constructing a logistics ...
In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback